Holdings of T. Rowe Price Health Care ETF
T. Rowe Price Exchange-Traded Funds, Inc. · Original filing · Compare with another fund · Report an error
- Net assets
- 23M $ including 22.8M $ in equities, 99.2 %
- Positions
- 94 in 12 countries
- Top ten
- 47.5 % of net assets
- Filed on
- Jun 30, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 3,209 | 3.8M $ | 16.71 % |
| 2 | UnitedHealth Group Inc | 3,614 | 1.5M $ | 6.52 % |
| 3 | Gilead Sciences Inc | 8,084 | 1M $ | 4.44 % |
| 4 | Thermo Fisher Scientific Inc | 1,890 | 947.6K $ | 4.11 % |
| 5 | Danaher Corp | 3,580 | 681.9K $ | 2.96 % |
| 6 | Cencora Inc | 2,240 | 633.9K $ | 2.75 % |
| 7 | Agilent Technologies Inc | 4,530 | 601.7K $ | 2.61 % |
| 8 | ALNYLAM PHARMACEUTICALS INC | 1,986 | 597.8K $ | 2.60 % |
| 9 | Intuitive Surgical Inc | 1,410 | 560.7K $ | 2.43 % |
| 10 | Insulet Corp | 3,601 | 548.3K $ | 2.38 % |
| 11 | Stryker Corp | 1,624 | 511.3K $ | 2.22 % |
| 12 | DYNE THERAPEUTICS INC | 21,069 | 467.9K $ | 2.03 % |
| 13 | ELANCO ANIMAL HEALTH INC | 17,864 | 439.6K $ | 1.91 % |
| 14 | Pfizer Inc | 18,228 | 438.9K $ | 1.91 % |
| 15 | CYTOKINETICS INC | 4,564 | 388.8K $ | 1.69 % |
| 16 | Waters Corp | 1,034 | 387.8K $ | 1.68 % |
| 17 | West Pharmaceutical Services Inc | 1,060 | 380.5K $ | 1.65 % |
| 18 | Ascendis Pharma A/S | 1,382 | 368.6K $ | 1.60 % |
| 19 | Biogen Inc | 1,654 | 357.4K $ | 1.55 % |
| 20 | McKesson Corp | 444 | 335.5K $ | 1.46 % |
| 21 | Dexcom Inc | 4,976 | 335.1K $ | 1.46 % |
| 22 | Immunome Inc | 15,009 | 318K $ | 1.38 % |
| 23 | BioNTech SE | 3,188 | 296.6K $ | 1.29 % |
| 24 | Humana Inc | 721 | 286.4K $ | 1.24 % |
| 25 | Denali Therapeutics Inc | 10,962 | 281.9K $ | 1.22 % |
| 26 | CVS Health Corp | 2,717 | 281.1K $ | 1.22 % |
| 27 | IDEXX Laboratories Inc | 515 | 271.1K $ | 1.18 % |
| 28 | VAXCYTE INC | 4,655 | 270.6K $ | 1.18 % |
| 29 | Mettler-Toledo International Inc | 174 | 222.3K $ | 0.97 % |
| 30 | HCA Healthcare Inc | 562 | 219.1K $ | 0.95 % |
| 31 | IMMATICS NV | 19,722 | 199.8K $ | 0.87 % |
| 32 | Repligen Corp | 1,430 | 195.1K $ | 0.85 % |
| 33 | Elevance Health Inc | 456 | 176.3K $ | 0.77 % |
| 34 | Shattuck Labs Inc | 25,348 | 175.9K $ | 0.76 % |
| 35 | Apogee Therapeutics Inc | 1,309 | 173.7K $ | 0.75 % |
| 36 | Becton Dickinson & Co | 1,098 | 166.2K $ | 0.72 % |
| 37 | MoonLake Immunotherapeutics | 7,823 | 152.3K $ | 0.66 % |
| 38 | Cooper Cos Inc/The | 2,088 | 149.7K $ | 0.65 % |
| 39 | CABALETTA BIO INC | 45,659 | 142K $ | 0.62 % |
| 40 | CG ONCOLOGY INC | 1,996 | 141.8K $ | 0.62 % |
| 41 | TENET HEALTHCARE CORP | 693 | 129.6K $ | 0.56 % |
| 42 | Bicara Therapeutics Inc | 4,103 | 121.8K $ | 0.53 % |
| 43 | ALIGNMENT HEALTHCARE INC | 4,840 | 115.2K $ | 0.50 % |
| 44 | SAREPTA THERAPEUTICS INC | 6,068 | 109K $ | 0.47 % |
| 45 | KYMERA THERAPEUTICS INC | 949 | 108.8K $ | 0.47 % |
| 46 | Revvity Inc | 926 | 103K $ | 0.45 % |
| 47 | Adaptive Biotechnologies Corp | 4,479 | 96.1K $ | 0.42 % |
| 48 | Molina Healthcare Inc | 416 | 95.1K $ | 0.41 % |
| 49 | BEONE MEDICINES LTD | 322 | 91.8K $ | 0.40 % |
| 50 | MAPLIGHT THERAPEUTICS INC | 2,543 | 91.1K $ | 0.40 % |
| 51 | Akeso Inc | 8,000 | 90.1K $ | 0.39 % |
| 52 | Kodiak Sciences Inc | 2,147 | 83.6K $ | 0.36 % |
| 53 | GeneDx Holdings Corp | 1,200 | 82.4K $ | 0.36 % |
| 54 | Dianthus Therapeutics Inc | 816 | 79.5K $ | 0.35 % |
| 55 | AVALO THERAPEUTICS INC | 4,287 | 79.2K $ | 0.34 % |
| 56 | Incyte Corp | 669 | 75.8K $ | 0.33 % |
| 57 | 4D Molecular Therapeutics Inc | 5,545 | 73.7K $ | 0.32 % |
| 58 | Xenon Pharmaceuticals Inc | 1,216 | 73.4K $ | 0.32 % |
| 59 | Novocure Ltd | 4,764 | 72.2K $ | 0.31 % |
| 60 | Eikon Therapeutics Inc | 5,522 | 72.1K $ | 0.31 % |
| 61 | ORUKA THERAPEUTICS INC | 746 | 71K $ | 0.31 % |
| 62 | Stoke Therapeutics Inc | 2,167 | 70.9K $ | 0.31 % |
| 63 | OnKure Therapeutics Inc | 15,335 | 69.9K $ | 0.30 % |
| 64 | Stevanato Group SpA | 3,869 | 69.9K $ | 0.30 % |
| 65 | Sartorius AG | 320 | 68.7K $ | 0.30 % |
| 66 | CARIS LIFE SCIENCES INC | 3,694 | 65.8K $ | 0.29 % |
| 67 | KARDIGAN INC | 2,695 | 64.3K $ | 0.28 % |
| 68 | Crinetics Pharmaceuticals Inc | 1,596 | 59.7K $ | 0.26 % |
| 69 | GRAIL Inc | 868 | 59.3K $ | 0.26 % |
| 70 | ARCUS BIOSCIENCES INC | 1,868 | 57.6K $ | 0.25 % |
| 71 | Maze Therapeutics Inc | 1,656 | 49.4K $ | 0.21 % |
| 72 | AKTIS ONCOLOGY INC | 1,517 | 48.9K $ | 0.21 % |
| 73 | Allogene Therapeutics Inc | 23,151 | 48.2K $ | 0.21 % |
| 74 | ORIC Pharmaceuticals Inc | 4,380 | 47.4K $ | 0.21 % |
| 75 | Rapport Therapeutics Inc | 1,127 | 47K $ | 0.20 % |
| 76 | AMYLYX PHARMACEUTICALS INC | 2,611 | 46.9K $ | 0.20 % |
| 77 | Spyre Therapeutics Inc | 525 | 46.6K $ | 0.20 % |
| 78 | DAMORA THERAPEUTICS INC | 1,788 | 46.5K $ | 0.20 % |
| 79 | Enliven Therapeutics Inc | 891 | 45.2K $ | 0.20 % |
| 80 | Procept Biorobotics Corp | 1,951 | 44.1K $ | 0.19 % |
| 81 | Disc Medicine Inc | 600 | 43.9K $ | 0.19 % |
| 82 | AVALYN PHARMA INC | 1,244 | 41K $ | 0.18 % |
| 83 | IONIS PHARMACEUTICALS INC | 509 | 40.4K $ | 0.18 % |
| 84 | Schrodinger Inc/United States | 2,236 | 36.3K $ | 0.16 % |
| 85 | Black Diamond Therapeutics Inc | 15,259 | 28.2K $ | 0.12 % |
| 86 | ABIVAX SA | 209 | 27.9K $ | 0.12 % |
| 87 | Erasca Inc | 1,460 | 26.7K $ | 0.12 % |
| 88 | Personalis Inc | 1,990 | 26.7K $ | 0.12 % |
| 89 | KARYOPHARM THERAPEUTICS INC | 2,470 | 24.1K $ | 0.10 % |
| 90 | PRIME MEDICINE INC | 6,152 | 22.7K $ | 0.10 % |
| 91 | IMMUNOVANT INC | 580 | 22.3K $ | 0.10 % |
| 92 | Biohaven Ltd | 1,458 | 21.7K $ | 0.09 % |
| 93 | CRISPR Therapeutics AG | 381 | 20.8K $ | 0.09 % |
| 94 | Annexon Inc | 2,087 | 11.9K $ | 0.05 % |
Sector breakdown
- Health care 67.6 %
- Unattributed 32.4 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 99.3 %
- HKD 0.4 %
- EUR 0.3 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 93.6 %
- Denmark 1.6 %
- Germany 1.6 %
- Netherlands 0.9 %
- Cayman Islands 0.7 %
- Hong Kong SAR China 0.4 %
- Canada 0.3 %
- Jersey 0.3 %
- Italy 0.3 %
- France 0.1 %
- British Virgin Islands 0.1 %
- Switzerland 0.1 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 82 | 21.4M $ | 93.60 % |
| 2 | Denmark | 1 | 368.6K $ | 1.61 % |
| 3 | Germany | 2 | 365.4K $ | 1.60 % |
| 4 | Netherlands | 1 | 199.8K $ | 0.87 % |
| 5 | Cayman Islands | 1 | 152.3K $ | 0.67 % |
| 6 | Hong Kong SAR China | 1 | 90.1K $ | 0.39 % |
| 7 | Canada | 1 | 73.4K $ | 0.32 % |
| 8 | Jersey | 1 | 72.2K $ | 0.32 % |
| 9 | Italy | 1 | 69.9K $ | 0.31 % |
| 10 | France | 1 | 27.9K $ | 0.12 % |
| 11 | British Virgin Islands | 1 | 21.7K $ | 0.09 % |
| 12 | Switzerland | 1 | 20.8K $ | 0.09 % |
Cite this page
Titelia. "Holdings of T. Rowe Price Health Care ETF". https://titelia.com/en/funds/S000092023